Tiziana Life Sciences
Price & Volume
Stats
See more52W Range | $1.14-$2.60 |
Market Cap | $187M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | -$3.5M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 10 days ago
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
Yahoo Finance • 10 days ago
Tiziana says updated data for multiple sclerosis therapy shows long-term safety
Yahoo Finance • last month
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
Yahoo Finance • 5 months ago
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
About
CEO | Dr. Ivor R. Elrifi Ph.D. |
CFO | Ms. Keeren Shah |
Address | 14/15 Conduit Street, London, United Kingdom, W1S 2XJ |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |